Equities

WELL Health Technologies Corp

WELL Health Technologies Corp

Actions
  • Price (EUR)3.44
  • Today's Change-0.034 / -0.98%
  • Shares traded1.40k
  • 1 Year change+20.67%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 14:40 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CAD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments434962
Total Receivables, Net1109171
Total Inventory1.181.370.79
Prepaid expenses6.404.234.69
Other current assets, total155.103.68
Total current assets176151142
Property, plant & equipment, net1038383
Goodwill, net508499472
Intangibles, net555571577
Long term investments611011
Note receivable - long term1.851.882.21
Other long term assets------
Total assets1,4091,3191,287
LIABILITIES
Accounts payable------
Accrued expenses125.566.46
Notes payable/short-term debt000
Current portion long-term debt/capital leases614357
Other current liabilities, total323735
Total current liabilities153137137
Total long term debt365315345
Total debt426358402
Deferred income tax183136
Minority interest788390
Other liabilities, total262162
Total liabilities642587669
SHAREHOLDERS EQUITY
Common stock752705634
Additional paid-in capital545244
Retained earnings (accumulated deficit)(64)(64)(65)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total26395.38
Total equity768732618
Total liabilities & shareholders' equity1,4091,3191,287
Total common shares outstanding241231209
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.